Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.

Duchon, Jennifer M; Levin, Myron J; Gershon, Anne A

Duchon, Jennifer M; Levin, Myron J; Gershon, Anne A.

Affiliation

Duchon JM; Division of Pediatric Infectious Diseases, Tufts Floating Hospital for Children, Boston, Massachusetts, USA.
Levin MJ; Division of Newborn Medicine, Tufts Floating Hospital for Children, Boston, Massachusetts, USA.
Gershon AA; Department of Pediatrics (Infectious Diseases), University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

J Pediatric Infect Dis Soc ; 9(4): 449-453, 2020 Sep 17.

Article in En | MEDLINE | ID: mdl-31774916

Subject(s)

Herpes Zoster/immunology; Herpes Zoster/prevention & control; Immune Sera/immunology; Post-Exposure Prophylaxis; Adult; Child, Preschool; Female; Humans; Immune Sera/adverse effects; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Male; Patient Safety; Pregnancy; Pregnancy Complications, Infectious/immunology

Key words

hyperimmune globulin; passive immunization; postexposure; preterm; varicella

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Post-Exposure Prophylaxis / Herpes Zoster / Immune Sera Limits: Adult / Child, preschool / Female / Humans / Infant / Male / Newborn / Pregnancy Language: En Journal: J Pediatric Infect Dis Soc Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google